Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michihiko Kuwano

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Cancer Science|November 20, 2008
Ets regulates peroxiredoxin1 and 5 expressions through their interaction with the high-mobility group protein B1Masaki Shiota, Hiroto Izumi, Naoya Miyamoto, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|February 22, 2005
Cisplatin resistance and transcription factorsTakayuki Torigoe, Hiroto Izumi, Hiroshi Ishiguchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatmentKoichi Azuma, Isamu Okamoto, Akihiko Kawahara, et al.
Oncotarget|May 2, 2019
The augmented expression of the cytidine deaminase gene by 5-azacytidine predicts therapeutic efficacy in myelodysplastic syndromesYuichi Murakami, Yoshizo Kimura, Akihiko Kawahara, et al.
Cancer Research|May 23, 2002
Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-riboseHiroshi Uchimiya, Tatsuhiko Furukawa, Masahiro Okamoto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2010
Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cellsYuji Basaki, Ken-Ichi Taguchi, Hiroto Izumi, et al.
Cancer Science|October 11, 2007
Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesisYusuke N Kimura, Kosuke Watari, Abbas Fotovati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinomaDaisuke Aoki, Yoshinao Oda, Satoshi Hattori, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 4, 2009
Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancerMasaki Kashihara, Koichi Azuma, Akihiko Kawahara, et al.
Cancer Letters|July 22, 2011
N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phaseJun Akiba, Yuichi Murakami, Masaki Noda, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Cancer Science|November 20, 2008
Ets regulates peroxiredoxin1 and 5 expressions through their interaction with the high-mobility group protein B1Masaki Shiota, Hiroto Izumi, Naoya Miyamoto, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|February 22, 2005
Cisplatin resistance and transcription factorsTakayuki Torigoe, Hiroto Izumi, Hiroshi Ishiguchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatmentKoichi Azuma, Isamu Okamoto, Akihiko Kawahara, et al.
Oncotarget|May 2, 2019
The augmented expression of the cytidine deaminase gene by 5-azacytidine predicts therapeutic efficacy in myelodysplastic syndromesYuichi Murakami, Yoshizo Kimura, Akihiko Kawahara, et al.
Cancer Research|May 23, 2002
Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-riboseHiroshi Uchimiya, Tatsuhiko Furukawa, Masahiro Okamoto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2010
Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cellsYuji Basaki, Ken-Ichi Taguchi, Hiroto Izumi, et al.
Cancer Science|October 11, 2007
Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesisYusuke N Kimura, Kosuke Watari, Abbas Fotovati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinomaDaisuke Aoki, Yoshinao Oda, Satoshi Hattori, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 4, 2009
Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancerMasaki Kashihara, Koichi Azuma, Akihiko Kawahara, et al.
Cancer Letters|July 22, 2011
N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phaseJun Akiba, Yuichi Murakami, Masaki Noda, et al.
Pageof 15